A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
CSPC Megalith Biopharmaceutical Co.,Ltd.
Kortuc, Inc.
Tasly Biopharmaceuticals Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Geneplus-Beijing Co. Ltd.
SCG Cell Therapy Pte. Ltd.
Corregene Biotechnology Co., Ltd